You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 97 No. 3, MARCH 1956 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluation of Oral Cholecystography in Liver Disease

CAPT. WILLIAM MANDEL; LT. L. M. GAINES, Jr.; LT. R. J. MARILLEY, Jr., MC

AMA Arch Intern Med. 1956;97(3):335-339.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Gall-bladder visualization by the oral route depends on an adequate blood level of dye following its absorption, its removal and excretion by the liver, and its entrance into and concentration by the gall bladder. It has been frequently stated that cholecystography is contraindicated in liver disease with jaundice, for one cannot determine whether the failure of visualization is due to liver or to gall-bladder disease. This study, which correlates the serum bilirubin level, the retention of sulfobromophthalein (Bromsulphalein) dye, and gall-bladder visualization in 40 patients with varying degrees of liver disease is an attempt to clarify the problem.

PROCEDURE

Forty patients with varying degrees of impaired liver function were selected for study. Tests of liver function and oral cholecystography were performed the same morning. Six tablets of iopanoic acid U. S. P. (Telepaque) were given the preceding evening. The sulfobromophthalein method consisted of the intravenous administration of 5 mg. of . . . [Full Text PDF of this Article]


Author Affiliations

U.S.A.F.


Footnotes

Submitted for publication Sept. 13, 1955.

Medical Department, 3345 U.S.A.F. Hospital, Chanute Air Force Base, Ill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1956 American Medical Association. All Rights Reserved.